Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

この会社は アーカイブに移動しました! 財務データは2023年5月4日以降更新されていません。

デュポンの分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROE分解では、純利益を株主資本で割ったものを構成比率の積として表します。

ROEを2つのコンポーネントに分解

Boston Scientific Corp.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2023/03/31 5.05% = 2.74% × 1.84
2022/12/31 3.97% = 2.15% × 1.85
2022/09/30 3.70% = 2.04% × 1.81
2022/06/30 5.12% = 2.75% × 1.87
2022/03/31 4.84% = 2.50% × 1.93
2021/12/31 6.26% = 3.23% × 1.94
2021/09/30 7.02% = 3.62% × 1.94
2021/06/30 3.64% = 1.86% × 1.96
2021/03/31 1.58% = 0.80% × 1.97
2020/12/31 -0.54% = -0.27% × 2.01
2020/09/30 23.80% = 12.01% × 1.98
2020/06/30 25.53% = 12.93% × 1.97
2020/03/31 31.06% = 14.24% × 2.18
2019/12/31 33.87% = 15.38% × 2.20
2019/09/30 11.24% = 4.07% × 2.76
2019/06/30 14.81% = 5.74% × 2.58
2019/03/31 19.46% = 7.55% × 2.58
2018/12/31 19.15% = 7.96% × 2.41
2018/09/30 — = — × 2.46
2018/06/30 — = — × 2.53
2018/03/31 — = — × 2.73

レポートに基づく: 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31), 10-K (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-Q (報告日: 2018-03-31).

2023年第1 四半期に株主資本利益率(ROE)が増加した主な理由は、資産利益率(ROA)で測定される収益性の増加です。

ROEを3つの要素に分解

Boston Scientific Corp.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2023/03/31 5.05% = 6.91% × 0.40 × 1.84
2022/12/31 3.97% = 5.50% × 0.39 × 1.85
2022/09/30 3.70% = 5.20% × 0.39 × 1.81
2022/06/30 5.12% = 7.17% × 0.38 × 1.87
2022/03/31 4.84% = 6.66% × 0.38 × 1.93
2021/12/31 6.26% = 8.76% × 0.37 × 1.94
2021/09/30 7.02% = 10.07% × 0.36 × 1.94
2021/06/30 3.64% = 5.19% × 0.36 × 1.96
2021/03/31 1.58% = 2.45% × 0.33 × 1.97
2020/12/31 -0.54% = -0.83% × 0.32 × 2.01
2020/09/30 23.80% = 36.65% × 0.33 × 1.98
2020/06/30 25.53% = 39.24% × 0.33 × 1.97
2020/03/31 31.06% = 39.75% × 0.36 × 2.18
2019/12/31 33.87% = 43.78% × 0.35 × 2.20
2019/09/30 11.24% = 10.49% × 0.39 × 2.76
2019/06/30 14.81% = 13.85% × 0.41 × 2.58
2019/03/31 19.46% = 18.08% × 0.42 × 2.58
2018/12/31 19.15% = 17.01% × 0.47 × 2.41
2018/09/30 — = — × — × 2.46
2018/06/30 — = — × — × 2.53
2018/03/31 — = — × — × 2.73

レポートに基づく: 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31), 10-K (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-Q (報告日: 2018-03-31).

2023年第1 四半期に株主資本利益率(ROE)が増加した主な理由は、純利益率で測定した収益性の増加です。

ROEを5つの要素に分解

Boston Scientific Corp.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 税負担 × 利息負担 × EBITマージン × 資産回転率 × 財務レバレッジ比率
2023/03/31 5.05% = 0.63 × 0.85 × 12.92% × 0.40 × 1.84
2022/12/31 3.97% = 0.61 × 0.71 × 12.70% × 0.39 × 1.85
2022/09/30 3.70% = 0.75 × 0.64 × 10.81% × 0.39 × 1.81
2022/06/30 5.12% = 0.80 × 0.68 × 13.13% × 0.38 × 1.87
2022/03/31 4.84% = 0.89 × 0.63 × 11.88% × 0.38 × 1.93
2021/12/31 6.26% = 0.97 × 0.76 × 11.92% × 0.37 × 1.94
2021/09/30 7.02% = 0.91 × 0.78 × 14.07% × 0.36 × 1.94
2021/06/30 3.64% = 1.05 × 0.61 × 8.07% × 0.36 × 1.96
2021/03/31 1.58% = 1.11 × 0.39 × 5.72% × 0.33 × 1.97
2020/12/31 -0.54% = — × -0.28 × 2.84% × 0.32 × 2.01
2020/09/30 23.80% = — × -7.40 × 0.52% × 0.33 × 1.98
2020/06/30 25.53% = — × -0.19 × 3.74% × 0.33 × 1.97
2020/03/31 31.06% = 17.01 × 0.36 × 6.53% × 0.36 × 2.18
2019/12/31 33.87% = 6.84 × 0.59 × 10.81% × 0.35 × 2.20
2019/09/30 11.24% = 1.10 × 0.73 × 12.96% × 0.39 × 2.76
2019/06/30 14.81% = 1.03 × 0.81 × 16.62% × 0.41 × 2.58
2019/03/31 19.46% = 1.15 × 0.84 × 18.57% × 0.42 × 2.58
2018/12/31 19.15% = 1.18 × 0.86 × 16.93% × 0.47 × 2.41
2018/09/30 — = — × — × — × — × 2.46
2018/06/30 — = — × — × — × — × 2.53
2018/03/31 — = — × — × — × — × 2.73

レポートに基づく: 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31), 10-K (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-Q (報告日: 2018-03-31).

2023年第1 四半期の株主資本利益率(ROE)が上昇した主な理由は、支払利息負担率で測定した支払利息の影響の増加です。

ROAを2つのコンポーネントに分解

Boston Scientific Corp.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2023/03/31 2.74% = 6.91% × 0.40
2022/12/31 2.15% = 5.50% × 0.39
2022/09/30 2.04% = 5.20% × 0.39
2022/06/30 2.75% = 7.17% × 0.38
2022/03/31 2.50% = 6.66% × 0.38
2021/12/31 3.23% = 8.76% × 0.37
2021/09/30 3.62% = 10.07% × 0.36
2021/06/30 1.86% = 5.19% × 0.36
2021/03/31 0.80% = 2.45% × 0.33
2020/12/31 -0.27% = -0.83% × 0.32
2020/09/30 12.01% = 36.65% × 0.33
2020/06/30 12.93% = 39.24% × 0.33
2020/03/31 14.24% = 39.75% × 0.36
2019/12/31 15.38% = 43.78% × 0.35
2019/09/30 4.07% = 10.49% × 0.39
2019/06/30 5.74% = 13.85% × 0.41
2019/03/31 7.55% = 18.08% × 0.42
2018/12/31 7.96% = 17.01% × 0.47
2018/09/30 — = — × —
2018/06/30 — = — × —
2018/03/31 — = — × —

レポートに基づく: 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31), 10-K (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-Q (報告日: 2018-03-31).

2023年第1 四半期に総資産利益率(ROA)が上昇した主な理由は、純利益率で測定した収益性の増加です。

ROAを4つの要素に分解

Boston Scientific Corp.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 税負担 × 利息負担 × EBITマージン × 資産回転率
2023/03/31 2.74% = 0.63 × 0.85 × 12.92% × 0.40
2022/12/31 2.15% = 0.61 × 0.71 × 12.70% × 0.39
2022/09/30 2.04% = 0.75 × 0.64 × 10.81% × 0.39
2022/06/30 2.75% = 0.80 × 0.68 × 13.13% × 0.38
2022/03/31 2.50% = 0.89 × 0.63 × 11.88% × 0.38
2021/12/31 3.23% = 0.97 × 0.76 × 11.92% × 0.37
2021/09/30 3.62% = 0.91 × 0.78 × 14.07% × 0.36
2021/06/30 1.86% = 1.05 × 0.61 × 8.07% × 0.36
2021/03/31 0.80% = 1.11 × 0.39 × 5.72% × 0.33
2020/12/31 -0.27% = — × -0.28 × 2.84% × 0.32
2020/09/30 12.01% = — × -7.40 × 0.52% × 0.33
2020/06/30 12.93% = — × -0.19 × 3.74% × 0.33
2020/03/31 14.24% = 17.01 × 0.36 × 6.53% × 0.36
2019/12/31 15.38% = 6.84 × 0.59 × 10.81% × 0.35
2019/09/30 4.07% = 1.10 × 0.73 × 12.96% × 0.39
2019/06/30 5.74% = 1.03 × 0.81 × 16.62% × 0.41
2019/03/31 7.55% = 1.15 × 0.84 × 18.57% × 0.42
2018/12/31 7.96% = 1.18 × 0.86 × 16.93% × 0.47
2018/09/30 — = — × — × — × —
2018/06/30 — = — × — × — × —
2018/03/31 — = — × — × — × —

レポートに基づく: 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31), 10-K (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-Q (報告日: 2018-03-31).

2023年第1 四半期の総資産利益率(ROA)が上昇した主な理由は、支払利息負担率で測定した支払利息の効果の増加です。

当期純利益率の分解

Boston Scientific Corp.、純利益率の分解(四半期データ)

Microsoft Excel
純利益率 = 税負担 × 利息負担 × EBITマージン
2023/03/31 6.91% = 0.63 × 0.85 × 12.92%
2022/12/31 5.50% = 0.61 × 0.71 × 12.70%
2022/09/30 5.20% = 0.75 × 0.64 × 10.81%
2022/06/30 7.17% = 0.80 × 0.68 × 13.13%
2022/03/31 6.66% = 0.89 × 0.63 × 11.88%
2021/12/31 8.76% = 0.97 × 0.76 × 11.92%
2021/09/30 10.07% = 0.91 × 0.78 × 14.07%
2021/06/30 5.19% = 1.05 × 0.61 × 8.07%
2021/03/31 2.45% = 1.11 × 0.39 × 5.72%
2020/12/31 -0.83% = — × -0.28 × 2.84%
2020/09/30 36.65% = — × -7.40 × 0.52%
2020/06/30 39.24% = — × -0.19 × 3.74%
2020/03/31 39.75% = 17.01 × 0.36 × 6.53%
2019/12/31 43.78% = 6.84 × 0.59 × 10.81%
2019/09/30 10.49% = 1.10 × 0.73 × 12.96%
2019/06/30 13.85% = 1.03 × 0.81 × 16.62%
2019/03/31 18.08% = 1.15 × 0.84 × 18.57%
2018/12/31 17.01% = 1.18 × 0.86 × 16.93%
2018/09/30 — = — × — × —
2018/06/30 — = — × — × —
2018/03/31 — = — × — × —

レポートに基づく: 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31), 10-K (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-Q (報告日: 2018-03-31).

2023年第1 四半期の純利益率が上昇した主な理由は、支払利息負担率で測定した支払利息の影響の増加です。